MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Vaccine Development & Manufacturing
Immunovaccine
Attachments
IMV - New Class of Immunotherapy That Programs T cells In Vivo
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Vaccines
*Architects: Vaccine Development & Manufacturing
*USAID-Contracts, Contractors & Awards
Industry: Canada
Children
2013: With $4.2M raise, Immunovaccine says it’s set through 2014, has 3 cancer vaccine trials in the works_medcitynews (2013)
2017: Leidos, Immunovaccine Expand Malaria Vaccine Devt Partnership
Chief Operating Officer Marc Mansour (2013)
clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health
Halifax, Nova Scotia, Canada
Jumps
Leidos Holdings, Inc. (NYSE: LDOS)